Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one that researchers are exploring with gusto. In a study published in 2023, ...

Alzheimer’s disease is notorious for robbing individuals of memory and cognitive function. Researchers have struggled for decades to find effective treatments, yet none have successfully halted or ...